Abstract
The use of a simple synthetic medium is essential for study on the growth and physiology ofCryptococcus neoformans. In the present study, a minimal synthetic liquid medium (MSM) was tested for the growth of 23C. neoformans strains. This medium contained a low concentration of glucose, ammonium sulphate and inorganic salts with a pH value of 4.5, but no amino acids or vitamins. The strains were starved for 4 days to eliminate nutrients which might have been carried over from their pre-culture medium. Then, they were inoculated in the MSM at an initial OD of 0.020 at 550 nm and incubated at 37 °C for 20 days. Cell growth was generally monitored daily by measuring the absorbance at 550 nm. The medium supported the growth of the strains tested and gave an average final OD of 0.500. The results obtained indicate thatC. neoformans may be autotrophic with respect to vitamins and in particular to thiamine. The MSM medium is easy to prepare and store. It is highly reproducible and useful for studies on the growth and physiology ofC. neoformans.
Similar content being viewed by others
References
Aguirremboa L, Montejo M, Prieta R, Uterga J, Gaztelurrutia L, Arce MD, Aguirre C. Meningitis criptococica y SIDA. Description clinica de 10 patientes. Enfer Infecc Microbiol Clin 1992; 10(2): 97–102.
Ainassie E, Paetznik V, Profltt R, Adler-Moore J, Bodey GP. Comparison of thein vitro activity of free and liposomeencapsulated amphotericin B. Eur J Clin Microbiol Infect Dis 1991; 10(8): 665–668.
Cameron ML, Bartlett JA, Gallis HA, Waskin HA. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Rev Infect Dis 1991; 13(1): 64–67.
Capell MS, Hassan T. Pancreatic disease in AIDS — a review. J Clin Gastroenterol 1993; 17(3): 254–263.
Gazapo Carretero E, Garcia Aguado C, Andrados de Llano M, Martinez Blanco ML, Verdejo Ortes J, Gonzales Lahos JM. Criptococcosis en patientes con SIDA: estudio de 19 casos. Rev Clin Esp 1992; 190(9): 450–454.
Ghigliotti G, Carrega G, Farris A, Burroni A, Nigro A, Pagano G, De Marchi R. Cutaneous cryptococcosis resembling molluscum contagiousum in a homosexual man with AIDS. Report of case and review of the literature. Acta Derm Venerol (Stockl) 1992; 72(3): 182–184.
Huctinson DO, Anderson NE, Ingram RJ, Thomas MG, Ellis Pegler RB, Bremmer DA, Parr DH. Cryptococcal meningitis in Auckland 1969–1989. NZ Med J 1991; 104(906): 57–59.
Joseph J, Strange C, Sahn C. Pleural effusions in hospitalized patients with AIDS. Ann Intern Med 1993; 118(11): 856–859.
Kaminaga Y, Shindo K, Ito A, Izima H. Mycological and clinical study of cryptococcosis in Yokohama City University Hospital during the period from 1965 to 1989. Kansenshougaku Zasshi (J Jpn Assoc Inf Dis) 1991; 65(4): 374–380.
Knight FR, Mackenzie DW, Evans BG, Porter K, Barret NJ, White GC. Increasing incidence of cryptococcosis in the United Kingdom. J Infect 1993; 27(2): 185–191.
Laroche R, Dupont B, Touze JE, Taelman H, Bogaerta J, Kadio A, M’Pele P, Latif A, Aubry P, Durbec JP et al. Cryptococcal meninigits associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatments with fluconazole. J Med Vet Mycol 1992; 30(1): 71–78.
Levitz SM. The ecology ofCryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991; 13(6): 1163–1169.
Macon WR, Lo SC, Poiesz BJ, Montefiori DC, Dawson MS, Mason TE, Michael PR, Cohen AG, Davis CM, Cousar JB et al. Acquired immunodeficiency syndrome-like illness associated with systemicMycoplasma fermentons infection in a human immunodeficiency virus-negative homosexual man. Humpathol 1993; 24(5): 554–558.
Martinez Vasquez C, De la Fuente J, Rivera A, Sopeña B, Bordon J, Ocampo A, Alvarez M. Criptococcosis del sistema nervioso central e infeccion por VIH. Caracteristicas clinicoevolutivas de 13 casos. An Med Interna 1993; 10(6): 265–270.
Medoff G, Dismukes WE, Pappagianis D, Diamond R, Gallis HA, Drutz D. Evaluation of new antifungal drugs for the treatment of systemic fungal infections. Infections Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; Nov. 15: IP S2474–2781.
Nichols L, Florentine B, Lewis W, Sattler, Rarick MU, Brynes RK. Bone marrow examination for the diagnosis of mycobacterial and fungal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991; 115(11): 1125–32.
Richardson MD. Opportunistic and pathogenic fungi. J Antimicrob Chemother 1991; 28: 1–11.
Sider L, Gabriel H, Curry DR, Pham MS. Pattern recognition of the pulmonary manifestations of AIDS on CT scans. Radiographies 1993; 13(4): 771–84.
Spitzer ED, Spitzer SG, Freudlich LF, Casadevall A. Persistence of initial infection in recurrentCryptococcus neoformans meningitis. Lancet 1993; 341(8845): 595–596.
Staensell JD. Fungal disease in HIV-infected persons: cryptococcosis, histoplasmosis and coccidioidomycosis. J Thorac Imaging 1991; 6(4): 28–35.
Stern JJ, Piertoski NA, Buckley RM, Braffman MN, Rinaldi MG. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients. Ann Pharmacother 1992; 26(7–8): 876–882.
Sugar AM. Overview: cryptococcosis in the patient with AIDS. Mycopathologia 1991; 114(3): 153–157.
Szalka A, Printz G. Opportunistic systemic mycosis. Orv Hetil 1991; 132(34): 1851–1856.
Anaissie E, Shawar R, Paetznik V, Ensign LG, Zitta W, LaRocco M. Two-site comparison of broth microdilution and semisolid agar dilution methods for suceptibility testing ofCryptococcus neoformans in three media. J Clin Microbiol 1993; 31(5): 1370–1372.
Ghannoum MA, Ibrahim AS, Yue F, Shafiq MC, Edwards JEJr, Criddle RS. Susceptibility testing ofCryptococcus neoformans: a microdilution technique. J Clin Microbiol 1992; 30(11): 2881–2886.
Kao CJ, Schwarz J. The isolation ofCryptococcus neoformans from pigeon nests. Am J Clin Pathol 1957; 27: 652–663.
Liftman ML. Capsule synthesis byCryptococcus neoformans. Trans NY Acad Sci 1958; 30: 623–648.
Varma A, Kwon-Chung KJ. DNA probe for strain typing ofCryptococcus neoformans. J. Clin Microbiol 1992; 30(11): 2960–2967.
Vartivarian SE. Iron assimilation inCryptococcus neoformans. J Med Vet Mycol 1992; 30(6): 443–450.
Wickerham LJ, Burton KA. Carbon assimilation tests for the classification of yeasts. J Bacteriol 1948; 56: 363–371.
Yamamoto T, Nohara K, Uchida K, Yamaguchi H. Purification and characterization of secretory proteinase ofCandida albicans. Microbiol Immunol 1992; 36(6): 637–641.
Sevilla MG, Odds FC. Development ofCandida albicans hyphae in different growth media-variations in the growth rates, cell dimensions and timing of morphogenetic events. J Gen Microbiol 1986; 32: 3083–3088.
Shepherd MG, Chiew YY, Ram SP, Sullivan PA. Germ tube induction inCandida albicans. Can J Microbiol 1980; 26: 21–26.
Vidotto V, Guevara Ochoa L, Michea Cortes J, Bruatto M. Optimal concentration of ammonium ion in a minimal synthetic medium for the growth ofCandida albicans. Mycopathologia 1991; 100: 139–142.
Vidotto V, Pugliese A, Gioannini P. 1987. Growth ofCandida albicans in a minimal synthetic medium without biotin. Mycopathologia 1987; 106: 7–15.
Bruatto M, Vidotto V, Maina AM. Growth ofCryptococcus neoformans in a thiamine-free medium. Mycopathologia 1992; 119(3): 129–132.
Shields AB, Ajello L. Medium for selective isolation ofCryptococcus neoformans. Science 1966; 151: 208–210.
Staib F, Seeliger HPR. Un noveau milieu selectif pour l’isolement deCryptococcus neoformans. Ann Inst Pasteur 1966; 110: 792–793.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vidotto, V., Aoki, S. & Campanini, G. A vitamin-free minimal synthetic medium forCryptococcus neoformans . Mycopathologia 133, 139–142 (1996). https://doi.org/10.1007/BF02373020
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02373020